22
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Development of a High Renin Model of Hypertension in the Cynomolgus Monkey

, , &
Pages 1395-1414 | Received 05 Apr 1991, Accepted 15 Jul 1991, Published online: 03 Jul 2009
 

Abstract

Hypertension was produced in cynomolgus monkeys by reducing blood flow to the left kidney by 60% via renal artery stenosis (2-kidney, 1-clip). Significant increases in mean arterial blood pressure (MABP) were observed within two to three weeks. Maximum increase (from 95±6 mmHg to 130±7 mmHg) occurred at about four to six weeks following renal artery stenosis and was sustained for more than 24 weeks. Plasma renin activity (PRA) was elevated concomitantly with the increase in MABP. PRA was raised to 42±3 ng angiotensin I/ml/hr six weeks after renal artery stenosis from a control PRA of 320.7 ng angiotensin I/ml/hr. At six months post renal artery stenosis, PRA was 33.424.2 ng angiotensin I/ml/hr. The angiotensin I1 (AII) receptor antagonist saralasin, the angiotensin I converting enzyme inhibitor captopril, and the renin inhibitor CGP 38,560 produced sustained reductions in MABP. The antihypertensive response to the renin inhibitor CGP 38,560 was associated with a reduction in PRA of >99%, and a >90% reduction in imnunoreactive AII. These studies demonstrate that high-renin hypertension can be induced in the cynomolgus monkey. This pathological model provides a useful method for investigating the antihypertensive effects of agents which antagonize the reninangiotensin system in a nonhuman primate.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.